YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE
Please be aware that the website you have requested is intended for the residents of countries in the European Union. The site may contain information on products or uses of those products that are not cleared, approved, or otherwise authorized in all countries or regions, including the US Food & Drug Administration.
WITH DO YOU WISH TO CONTINUE AND EXIT THIS WEBSITE?
Company to launch Hemanext ONE® RBC Processing and Storage System in select European markets in 2021, with wider distribution in Europe and the Americas in 2022 and future years LEXINGTON, Mass., Apr 13, 2021, PRNEWSWIRE – Hemanext Inc ., a privately held US-based...
Sickle Cell Disease Association of America, Inc. Launches New Educational Materials to Support Children’s Blood Transfusion Pictorial booklet for children and companion brochure for caregivers sponsored by Hemanext HANOVER, Md. and LEXINGTON, Mass., April 1, 2021...
Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with...
In Commemoration of Jimmy Devarie Conde (1969 – 2020) With deep sadness, we inform you of the sudden passing on November 5th of Jimmy Devarie, Plant Manager of the NHS Manufacturing facility. Jimmy was admired, respected, and loved by his team and colleagues here at...
Hemanext to Present New Red Blood Cell Research Data at AABB 2020 Four abstracts add to the growing body of evidence supporting hypoxic storage of RBCs LEXINGTON, Mass., September 29, 2020 Hemanext Inc., a privately held medical technology company dedicated to...
Celebrating David Herman (1946 – 2020) With deep sadness, we record the untimely death in London on June 3rd of our fellow Board Director, investor and friend, David Herman. David served Hemanext as a member of the board for 10 years. He brought to this role a...
